Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Sascha Ellers"'
Autor:
Zeynep Eroglu, Joe Ensor, Meenakshi Malhotra, Paul Billings, Angel Rodriguez, Alexey Aleshin, Ling Gao, Sarah Sawyer, Pashtoon Murtaza Kasi, Sascha Ellers, George Ansstas, Michael Krainock, Sakti Chakrabarti, Andrew Poklepovic, Minu Maninder
Publikováno v:
BMJ Open, Vol 12, Iss 5 (2022)
Externí odkaz:
https://doaj.org/article/1710b670c7d04923bb1d5cd95028e149
Autor:
Scott Kopetz, Axel Grothey, Shifra Krinshpun, Meenakshi Malhotra, Paul Billings, Angel Rodriguez, Alexey Aleshin, Sarah Sawyer, Michelle Munro, Pashtoon Murtaza Kasi, Jessica Guilford, Sascha Ellers, Jacob Wulff, Nicole Hook, Allyson Koyen Malashevich, Solomon Moshkevich
Publikováno v:
BMJ Open, Vol 11, Iss 9 (2021)
Introduction Colorectal cancer (CRC) is a highly prevalent disease, wherein, ~30%–40% of patients with CRC relapse postresection. In some patients with CRC, adjuvant chemotherapy can help delay recurrence or be curative. However, current biomarkers
Externí odkaz:
https://doaj.org/article/9887af290e0143cf93aa6bd064490660
Autor:
Pashtoon Murtaza Kasi, Sakti Chakrabarti, Sarah Sawyer, Michael Krainock, Andrew Poklepovic, George Ansstas, Minu Maninder, Meenakshi Malhotra, Joe Ensor, Ling Gao, Zeynep Eroglu, Sascha Ellers, Paul Billings, Angel Rodriguez, Alexey Aleshin
Publikováno v:
BMJ open. 12(5)
IntroductionImmunotherapy (IO) has transformed the treatment paradigm for a wide variety of solid tumours. However, assessment of response can be challenging with conventional radiological imaging (eg, iRECIST), which do not precisely capture the uni
Autor:
Angel Rodriguez, Meenakshi Malhotra, Shifra Krinshpun, Sascha Ellers, Nicole Hook, S Sawyer, Solomon Moshkevich, Michelle Munro, Alexey Aleshin, Jacob Wulff, Jessica Guilford, Pashtoon Murtaza Kasi, Axel Grothey, Scott Kopetz, Paul Billings, Allyson Koyen Malashevich
Publikováno v:
BMJ Open
BMJ Open, Vol 11, Iss 9 (2021)
BMJ Open, Vol 11, Iss 9 (2021)
IntroductionColorectal cancer (CRC) is a highly prevalent disease, wherein, ~30%–40% of patients with CRC relapse postresection. In some patients with CRC, adjuvant chemotherapy can help delay recurrence or be curative. However, current biomarkers